Optimal Bayesian-feasible dose escalation for cancer phase I trials

Statistics and Probability Letters

Volumn 38, Issue 3, 1998, Pages 215-220

  Zacks, S ^a   Rogatko, A ^b   Babb, J ^b  

^a BINGHAMTON UNIVERSITY   (United States)

^b FOX CHASE CANCER CENTER   (United States)

Author keywords

Bayesian adaptive procedure; Bayesian feasible scheme; Cancer phase I clinical trials; Consistent escalation scheme; Constrained optimization; Dose escalation scheme

Indexed keywords

EID: 0032525496     PISSN: 01677152     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0167-7152(98)00016-9     Document Type: Article

References (10)

1. Babb, J., Rogatko, A., Zacks, S., 1997. Cancer Phase I Clinical Trials: Efficient Dose Escalation With Overdose Control, Statistics in Medicine (in press).
2. Eichhorn, B.H., Zacks, S., 1973. Sequential search of an optimal dosage, 1. Jour. Amer. Statistic. Assoc. 68, 594-598.
3. Gastonis, C., Greenhouse, J.B., 1992. Bayesian methods for Phase I Clinical Trials. Statist. Med. 11, 1377-1389.
4. O'Quigley, J., Pepe, M., Fisher, L., 1990. Continual reassessment method: a practical design for Phase I clinical trials in cancer. Biometrics 46, 33-38.
5. O'Quigley, J., Chevret, S., 1991. Methods for dose finding studies in cancer clinical trials: A review and result of Monte Carlo study. Statist. Med. 10, 1047-1664.
6. Shiryayev, A.N., 1984. Probability. Springer, New York.
7. Storer, B.E., 1989. Design and analysis of phase I clinical trials. Biometrics 45, 925-937.
8. Tsutakawa, R.K., 1980. Selection of dose levels for estimating a percentage point of a logistic quantal response curve. J. Roy. Statist. Soc. Ser. C 29, 25-33.
9. Zacks, S., 1996. Adaptive designs for parametric models. In: Handbook of Statistics, vol. 13, Chapter 5. Elsevier, Amsterdam.
10. Zacks, S., Eichhorn, B.H., 1975. Sequential search of optimal dosages: The linear regression case. In: Statistical Design and Linear Models. North-Holland, Amsterdam.